Diagnostic accuracy of NaF PET-MRI in differentiating bone metastases from benign bone lesions in metastatic prostate cancer.
Taylor Stone 1 and Luis Beltran 2
New York University, New York, NY, United
York University, NY, United States
NaF PET-MRI as a hybrid imaging study shows higher
specificity, sensitivity, and overall accuracy than bone
scintigraphy, PET or MRI in isolation in differentiating
between metastatic and benign bone lesions. Accurately
defining the number of lesions has important treatment
implications as prostate cancer treatment is generally
based on disease burden.
This abstract and the presentation materials are available to members only;
a login is required.